When was Append Medical founded?

Append Medical was founded in 2016 and raised its 1st funding round 5 years after it was founded.

Where is Append Medical located?

Append Medical is headquartered in Or Yehuda, Israel.

Who is the current CEO of Append Medical?

Zachi Berger of Append Medical.

How many employees does Append Medical have?

As of Aug 31, 2026, the latest employee count at Append Medical is 26.

Is Append Medical a funded company?

Append Medical is a funded company, having raised a total of $11.8M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Aug 04, 2021.

When was the latest funding round of Append Medical?

Append Medical's latest funding was a $***** Series A round on Jul 06, 2023, with participation from 2 investors. Its primary sector is Cardiac and Vascular Disorders. Globally, the Cardiac and Vascular Disorders sector has seen $1.93B in funding in 2026 to date.

Where does Append Medical rank among its competitors?

Append Medical ranks 10th amongst 71 active competitors, of which 23 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was AtaCor Medical, which secured $75M in Oct, 2025.

Who are the top competitors of Append Medical?

Append Medical's top competitors include AtaCor Medical, EBR Systems and AtriCure. Among them, AtaCor Medical secured the most recent funding round in October, 2025.

Append Medical - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of a device for the left atrial appendage closure system. The system is used to prevent the blood clot leakage from the Left Atrial Appendage through LAA complete closure.

Website: appendmedical.com
Phone Number: +972 **********

Key Metrics

Founded Year

2016

Location

Or Yehuda, Israel

Stage

Series A

Total Funding

$11.8M in 2 rounds

Latest Funding Round

Series A, Jul 06, 2023, $*****

Investors

ALIVE & 4 more

Ranked

10^th among 71 active competitors

Employee Count

26 as on Aug 31, 2026

Similar Companies

AtaCor Medical & 90 more

View Append Medical's full profile

Append Medical has raised a total funding of $11.8M over 2 rounds. Its first funding round was on Aug 04, 2021. Its latest funding round was a Series A round on Jul 06, 2023 for $*****. 2 investors participated in its latest round. Append Medical has 5 institutional investors.

Here is the list of recent funding rounds of Append Medical:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 06, 2023	1274562	Series A	3032584	9180068	6113417	4320663
Aug 04, 2021	4314916	Series A	2186889	6004699	5676795	7898717

Access funding benchmarks and valuations. Sign up today!

View details of Append Medical's funding rounds and investors

The founders of Append Medical is Zachi Berger.

Here are the details of Append Medical's key team members:

Zachi Berger: Founder & CEO of Append Medical and founder of 1 other company.
Contact Info: 1 email address

View details of Append Medical's Founder profiles and Board Members

Append Medical's employee count trend

Append Medical has 26 employees as of Aug 26. Here is Append Medical's employee count trend over the years:

Uncover Append Medical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Append Medical include AtaCor Medical, EBR Systems and AtriCure. Here is the list of Top 10 competitors of Append Medical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AtaCor Medical 2014, San Clemente (United States), Series D	Transforming cardiac rhythm management with innovative extravascular pacing and defibrillation solutions	$137M	aMoon, Broadview Ventures & 7 others	65/100
2nd	EBR Systems 2003, Sunnyvale (United States), Public	Revolutionizing cardiac rhythm management with leadless pacing technology for heart failure	$180M	Brandon Capital, M.H. Carnegie & Co & 12 others	60/100
3rd	AtriCure 2000, Mason (United States), Public	Medical device company focused on atrial fibrillation and pain management	-	Stage Capital, Camden Partners & 2 others	59/100
4th	CardioFocus 1990, Marlborough (United States), Series E	Endoscopically guided catheter for ablation	$261M	H.I.G. Capital, KBL & 22 others	59/100
5th	CathVision 2013, Copenhagen (Denmark), Series B	Provider and developer of an AI-based cardiac ablation therapy software and device	$36.1M	Vaekstfonden, Borean Innovation & 6 others	57/100
6th	Kestra Medical Technologies 2014, Kirkland (United States), Public	Device to protect and support patients at risk of cardiovascular disorders	$196M	Bain Capital Life Sciences, Longitude Capital ... & 9 others	54/100
7th	TyRx 1998, Monmouth Junction (United States), Acquired	Antibacterial envelopes for cardiac implants	$70.8M	MemorialCare Innovation Fund, HLM Venture Partners ... & 6 others	47/100
8th	Cameron Health 2001, San Clemente (United States), Acqui-Hired	Subcutaneous Implantable Defibrillator	$158M	Alloy Ventures, Western Technology Investment ... & 14 others	46/100
9th	nContact Surgical 2005, Morrisville (United States), Acquired	Cardiac ablation technology	$53.2M	Finistere Ventures, Harbert Management & 5 others	45/100
10th	Append Medical 2016, Or Yehuda (Israel), Series A	Developer of a device for the left atrial appendage closure system	$11.8M	ALIVE, Saber & 3 others	45/100